#ASCO25: Kura spells out pivotal AML trial win as it gears up to compete with Syndax
Kura Oncology said one-quarter of patients with certain forms of advanced acute myeloid leukemia went into complete remission after receiving its targeted therapy. In 112 patients from both its Phase 1b and Phase 2 studies ...
Kura Oncology said one-quarter of patients with certain forms of advanced acute myeloid leukemia went into complete remission after receiving its targeted therapy.
In 112 patients from both its Phase 1b and Phase 2 studies ...
